Skip to main content

Global Automated External Defibrillators Market Projected To Grow At A Significant Rate Of 7.2% From 2017–2025: Credence Research

According to the latest report published by Credence Research, Inc. “Automated External Defibrillators Market Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global automated external defibrillators market is projected to grow at a significant rate of 7.2% from 2017-2025.
Browse the full report Automated External Defibrillators Market Growth, Future Prospects and Competitive Analysis, 2017-2025 at http://www.credenceresearch.com/report/automated-external-defibrillators-market
Market Insights                                                  
Automated external defibrillators (AEDs) are portable and lightweight devices that deliver electrical shock to the heart in case of sudden cardiac arrest (SCA). SCA is a condition wherein the heart stops beating unexpectedly, leading to death if not treated at the earliest. According to America Heart Association (AHA), SCA is a leading cause of death globally, accounting for more than 350,000 medical emergencies every year in the U.S. alone. SCA is said to claim one life every 90 seconds which is more deaths than lung cancer, breast cancer or AIDS. 95% of the people who experience SCA die due to lack of accessible treatment available at the site. To overcome this scenario, public access defibrillators (PAD) programs have been introduced by governments in North America and Europe. Under such programmes, automated external defibrillators are placed in the conspicuous and crowded places such as shopping malls, airports, convention centers, metro stations, etc. that can be used by non-medical users to save lives of the people suffering from SCA.
On the basis of defibrillator type, the global automated external defibrillators market is segmented into semi-automated external defibrillators and fully automatic external defibrillators. Fully automated external defibrillators deliver the shock automatically by analyzing the cardiac rhythm. Technological advancements in the nature of automated external defibrillators to make them user friendly for unskilled care providers is driving the fully automatic external defibrillators market.
North America emerged as the leading region in the global automated external defibrillators market on account of growing geriatric population susceptible to cardiac diseases. Cardiac diseases have the highest mortality rate in the U.S., accounting for 610,000 deaths every year. Supportive government initiatives and product development are other factors driving the automated external defibrillators market in the region. Asia Pacific is the fastest growing region due to technologically advanced defibrillators entering the market, growing prevalence of target diseases and rise in the geriatric population fuelling the market growth in Asia Pacific.
Market Competition Assessment:
The automated external defibrillators market comprises giant medical devices manufactures Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Philips Healthcare, Zoll Medical Corporation, Biotronik Se & Co. Kg., Physio-Control International, Inc., Cardiac Science Corporation, Sorin Group, and Nihon Kohden Corporation.
Table of Content
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Automated External Defibrillators Market Portraiture
2.2. Global Automated External Defibrillators Market, by Defibrillator Type, 2016 (US$ Mn)
2.3. Global Automated External Defibrillators Market Share, by Geography, 2016 (Value %)
Chapter 3. Automated External Defibrillators Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2016
3.6. Porter’s Five Forces Analysis
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016...........
Company Profiles
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290
 

Comments

Popular posts from this blog

Home Healthcare Market has Positive Long-Term Growth Outlook 2017-2023: Credence Research

Credence Research has recently issued a new market assessment report titled “Home Healthcare – Growth, Future Prospects and Competitive Analysis, 2016 – 2023”. The global Home Healthcare Market study provides a comprehensive view of the ongoing and future phases of the Home Healthcare industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/home-healthcare-market Based on geographic/regional distribution the global Home Healthcare Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Home Healthcare Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and...

Rheumatoid Arthritis Therapeutics Market Assessment Report Now Available at Credence Research

Credence Research has recently issued a new market assessment report titled “ Rheumatoid Arthritis Therapeutics  – Growth, Future Prospects and Competitive Analysis, 2016 – 2024”. The global Rheumatoid Arthritis Therapeutics Market study provides a comprehensive view of the ongoing and future phases of the Rheumatoid Arthritis Therapeutics industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/rheumatoid-arthritis-therapeutics-market Based on geographic/regional distribution the global Rheumatoid Arthritis Therapeutics Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Rheumatoid Arthritis Therapeutics Market based on geogra...

Global Liquid Biopsy Market Dynamics, Forecast, Analysis and Supply Demand 2022: Credence Research

According to the latest report published by Credence Research, Inc. “ Liquid Biopsy Market   Growth, Future Prospects and Competitive Analysis, 2016-2022,” the liquid biopsy market was valued at USD 1,881.9 Mn in 2015, and is expected to reach USD 10,850.3 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022. Browse the full report Liquid Biopsy: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at  http://www.credenceresearch.com/report/liquid-biopsy-market Market Insights In the past, tissue samples extracted through biopsy were evaluated to detected malignancy. However, some micrographs delivered inconsistent and ambiguous results, thus demanding repeated procedure. The advent of molecular diagnostics and next generation sequencing offered pathologists with a powerful tool for efficient diagnosis. Even with such advances, cancer diagnosis still remained subject to the limitation of availability of biopsied tissue, which fu...